Consultant haematologist Jonathan Pattinson reports from the UK NEQAS for Blood Coagulation annual scientific meeting, which drew international support from scientists, clinicians and contributors.
Clinical and Laboratory Haemostasis 2016, the UK NEQAS for Blood Coagulation (BC) Annual Scientific and Participants’ Meeting, was held at Sheffield Hallam University in June last year. The meeting was very well attended both by laboratory scientists and clinicians on both days. Following a welcome address as Director of UK NEQAS BC, Professor Isobel Walker introduced Dr Will Lester (Birmingham), who chaired the first session on antiphospholipid syndrome.
Antiphospholipid surveys
Antiphospholipid syndrome (APS) is an important clinical problem that presents great difficulty to clinicians and biomedical scientists alike. Patients suffer from repeated venous and arterial thromboses, and also pregnancy-associated problems. Laboratory diagnosis of the condition relies on the demonstration of anticardiolipin (ACL), β2-glycoprotein 1 (β2GP1) antibodies and the lupus anticoagulant in affected patients.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
